MCP-1、CCR2与动脉粥样硬化研究进展
摘要
动脉粥样硬化(AS)是一种慢性炎症性疾病,近年来越来越多的证据表明单核细胞趋化蛋白-1(MCP-1)及其受体CCR2在AS发生和发展过程中具有重要的意义。
出处
《科技信息》
2011年第6期110-110,共1页
Science & Technology Information
参考文献10
-
1Charo, I.F. and R.M. Ransohoff, The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med,2006. 354 (6): p. 610-21.
-
2Yla-Herttuala, S., et al., Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A,1991.88(12): p. 5252-6.
-
3Gu, L., et al., Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density fipoprotein receptor-deficient mice. Mol Ce11,1998. 2(2): p. 275-81.
-
4Dawson, T.C., et al., Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient nfice. Atherosclerosis, 1999. 143(1): p. 205-11.
-
5Schober, A., et al., Crucial role of the CCL2/CCR2 axis in neoinhyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruimaent and CCL2 presentation on platelets. Circ Res,2004. 95(11): p. 1125-33.
-
6Steinberg, D., Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation,1997.95(4): p. 1062-71.
-
7Cushing, S.D., et al., Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Nail Acad Sci U S A,1990.87(13): p. 5134-8.
-
8Han, ICH., et al., Chemokine receptor CCR2 expression and monocyte chemoattractant protein-l-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler Thromb Vasc BioL1998.18(12): p.1983-91.
-
9Roque, M., et aL, CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vase Biol,2002.22(4): p.554-9.
-
10Ni, W,, et al., New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation,2001.103(16): p.2096-101.
-
1朱娜,姚定金,周晓燕.AMPK在慢性炎症性疾病中的研究进展[J].生命的化学,2016,36(3):335-340. 被引量：3
-
2姜海燕,曲波,金世柱.干细胞疗法治疗炎症性肠病的应用[J].胃肠病学和肝病学杂志,2012,21(6):498-501. 被引量：5
-
3大谷明夫,胡宜.慢性炎症性疾病与趋化因子[J].日本医学介绍,2005,26(4):163-166. 被引量：2
-
4张铮,金早蓉,姚希,沈丽佳,张国志.肿瘤坏死因子α与OLP癌变的关系[J].临床口腔医学杂志,2006,22(8):502-503.
-
5杨祎.PEPITEM:新型B细胞来源肽段参与调控T细胞向炎症部位募集过程[J].生理科学进展,2015,46(3):196-196.
-
6杨祎.Notch信号通路调节葡萄糖摄取而控制记忆型CD4^+ T细胞存活[J].生理科学进展,2015,46(1):5-5.
-
7曹天翼,唐国瑶.OLP角质形成细胞体外培养的研究进展[J].临床口腔医学杂志,2015,31(4):254-255.
-
8王霖,王文杰.破骨细胞在类风湿性关节炎骨破坏中的作用及其调控机制[J].生理科学进展,2004,35(3):269-272. 被引量：37
-
9向阳芳,石敏,徐智.NF-κB的负性调控机制在肿瘤发展与治疗的研究进展[J].现代生物医学进展,2014,14(16):3153-3157. 被引量：8
-
10杨华,张知贵,谯时文,Qunzhou Zhang.缺氧诱导因子-1与干细胞功能调控[J].西华师范大学学报（自然科学版）,2010,31(4):422-428.
